Lv52
940 积分 2024-09-10 加入
Virological response and resistance profile in highly treatment‐experienced HIV‐1‐infected patients switching to dolutegravir plus boosted darunavir in clinical practice
27天前
已完结
Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial
27天前
已关闭
Lenacapavir treatment–emergent HIV-1 capsid resistance mutations are frequently associated with replication defects
3个月前
已完结
Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis
4个月前
已完结
Meta-analysis and systematic review of the efficacy and resistance for human immunodeficiency virus type 1 integrase strand transfer inhibitors
4个月前
已完结
Proactive Telehealth-Based Sepsis Transition and Recovery Support, Hospital Readmission, and Mortality
5个月前
已完结
Hypervirulent Klebsiella pneumoniae: watch the eyes
5个月前
已完结
Proactive Telehealth-Based Sepsis Transition and Recovery Support, Hospital Readmission, and Mortality
8个月前
已完结
Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial
8个月前
已完结
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
9个月前
已完结
皖公网安备34019202002308
